Interim results from a phase 1/2 precision medicine study of PLX8394-a next generation BRAF inhibitor Meeting Abstract
| Authors: | Janku, F.; Sherman, E. J.; Parikh, A. R.; Feun, L. G.; Tsai, F.; Allen, E.; Zhang, C.; Severson, P.; Inokuchi, K.; Walling, J.; Averbuch, S.; Tarcic, G.; Bollag, G. |
| Abstract Title: | Interim results from a phase 1/2 precision medicine study of PLX8394-a next generation BRAF inhibitor |
| Meeting Title: | 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 138 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2020 Oct 24-25 |
| Meeting Location: | Virtual |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-10-01 |
| Start Page: | S2 |
| End Page: | S3 |
| Language: | English |
| ACCESSION: | WOS:000582839900006 |
| PROVIDER: | wos |
| DOI: | 10.1016/s0959-8049(20)31078-9 |
| Notes: | Meeting abstract: 5LBA -- Source: Wos |
